We are live on ! Find out more
NFSG

Newbridge Financial Services Group Portfolio holdings

AUM $608M
1-Year Est. Return 31.28%
This Fund
S&P 500
This Quarter Est. Return
+20.76%
1 Year Est. Return
+31.28%
3 Year Est. Return
+114.56%
5 Year Est. Return
+128.99%
10 Year Est. Return
AUM
$616M
AUM Growth
+$204M
Cap. Flow
+$123M
Cap. Flow %
20.03%
Top 10 Hldgs %
29.33%
Holding
1,379
New
333
Increased
338
Reduced
213
Closed
62

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$16.9M
2
T icon
AT&T
T
+$3.59M
3
PLTR icon
Palantir
PLTR
+$3.58M
4
MMM icon
3M
MMM
+$3.24M
5
MO icon
Altria Group
MO
+$3.18M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Communication Services 7.12%
3 Consumer Discretionary 6.46%
4 Financials 5.89%
5 Consumer Staples 3.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VANI icon
1276
Vivani Medical
VANI
$115M
$133 ﹤0.01%
103
YOLO icon
1277
AdvisorShares Pure Cannabis ETF
YOLO
$29.5M
$132 ﹤0.01%
+70
New +$129
HUMA icon
1278
Humacyte
HUMA
$186M
$125 ﹤0.01%
60
TCRT icon
1279
Alaunos Therapeutics
TCRT
$4.66M
$116 ﹤0.01%
24
HPE icon
1280
Hewlett Packard
HPE
$66.5B
$102 ﹤0.01%
+5
New +$84
LBRDA icon
1281
Liberty Broadband Class A
LBRDA
$4.86B
$98 ﹤0.01%
1
FWONA icon
1282
Liberty Media Series A
FWONA
$22.4B
$95 ﹤0.01%
1
METV icon
1283
Roundhill Ball Metaverse ETF
METV
$213M
$85 ﹤0.01%
5
-100
-95% -$1.48K
ASRT
1284
DELISTED
Assertio
ASRT
$80 ﹤0.01%
8
NVNO
1285
enVVeno Medical
NVNO
$7.14M
$80 ﹤0.01%
+1
New +$118
LLYVA icon
1286
Liberty Live Group Series A
LLYVA
$9.12B
$79 ﹤0.01%
1
CENN icon
1287
Cenntro
CENN
$8.46M
$77 ﹤0.01%
2
BCTXW
1288
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$75 ﹤0.01%
+1,000
New +$90
SKYE icon
1289
Skye Bioscience
SKYE
$20.5M
$75 ﹤0.01%
18
LIXTW
1290
DELISTED
Lixte Biotechnology Warrants
LIXTW
$72 ﹤0.01%
+2,500
New +$82
TLRY icon
1291
Tilray
TLRY
$632M
$69 ﹤0.01%
17
-40
-70% -$182
BENF icon
1292
Beneficient
BENF
$46.9M
$56 ﹤0.01%
24
IBO
1293
Impact BioMedical
IBO
$47.3M
$56 ﹤0.01%
86
QVCGA
1294
DELISTED
QVC Group Inc Series A
QVCGA
$50 ﹤0.01%
18
-1
-5% -$6
BATRK icon
1295
Atlanta Braves Holdings Series B
BATRK
$3.27B
$47 ﹤0.01%
1
NXLIW
1296
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$47 ﹤0.01%
+1,000
New +$129
AENTW icon
1297
Alliance Entertainment Holding Corp Warrants
AENTW
$3.97M
$32 ﹤0.01%
175
TBHC
1298
DELISTED
The Brand House Collective
TBHC
$27 ﹤0.01%
25
ACB
1299
Aurora Cannabis
ACB
$175M
$21 ﹤0.01%
5
NVVE
1300
DELISTED
Nuvve Holding Corp
NVVE
0

Similar funds

Newbridge Financial Services Group's Q2 2025 Portfolio in Review

As of Q2 2025, Newbridge Financial Services Group held 1,379 positions worth $616M, up 50% from $412M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Newbridge Financial Services Group deployed $123M of net new capital in Q2 2025, opening 333 new positions and adding to 338 existing holdings. Its largest new stake was Ares Capital: 127,969 shares worth $2.81M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Global X NASDAQ-100 Covered Call ETF, an estimated $2.52M trimmed.

  • Newbridge Financial Services Group's largest Q2 2025 buy was Ares Capital: 127,969 shares worth $2.81M.
  • Newbridge Financial Services Group added most to JPMorgan Ultra-Short Income ETF in Q2 2025, an estimated $16.9M increase.
  • Newbridge Financial Services Group's biggest Q2 2025 reduction was Global X NASDAQ-100 Covered Call ETF, cutting an estimated $2.52M.
  • Newbridge Financial Services Group fully exited Equinix in Q2 2025, selling an estimated $189K.
  • Newbridge Financial Services Group's ten largest holdings make up 29% of its $616M portfolio in Q2 2025.
  • Newbridge Financial Services Group opened 333 new positions and closed 62 in Q2 2025.
  • Newbridge Financial Services Group's portfolio value rose 50% quarter-over-quarter to $616M.

Based on Newbridge Financial Services Group's 13F filing for Q2 2025, filed 19 Aug 2025.